Combining Neuropsychiatry and Business-Building Expertise

Psy Therapeutics’ team of seasoned executives and neuropsychiatric leaders has a proven ability to create significant and sustained value for patients and stakeholders. Our team is supported by a stellar and actively engaged Scientific Advisory Board (SAB) that helps guide Psy in crafting and executing its R&D strategies and programs.

team members

David S. Barlow

Chair & CEO

team members

Bill Carlezon, PhD

SAB Member

team members

Alan Cross, PhD

CSO & Chair, SAB

team members

Maurizio Fava, MD

Co-Founder, SAB Member

team members

Daniel Fass, PhD

SAB Member

team members

Stephen Haggarty, PhD

SAB Member

team members

Jacob Hooker, PhD

SAB Member

team members

Kelly Kearney

Director, Investor Relations and Communications

team members

Sachin Patel, MD, PhD

SAB Member

team members

Jerry Rosenbaum, MD

Co-Founder, SAB Member

team members

Jeff Troderman, CPA

Chief Financial Officer

team members

William Wagner

Manager, R&D Operations